Cambridge Investment Research Advisors’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,893
Closed -$370K 3219
2023
Q3
$370K Buy
15,893
+99
+0.6% +$2.44K ﹤0.01% 2334
2023
Q2
$393K Buy
15,794
+1,697
+12% +$43K ﹤0.01% 2314
2023
Q1
$366K Sell
14,097
-2,895
-17% -$74.8K ﹤0.01% 2309
2022
Q4
$435K Buy
16,992
+8,780
+107% +$225K ﹤0.01% 2128
2022
Q3
$208K Sell
8,212
-544
-6% -$14.4K ﹤0.01% 2669
2022
Q2
$230K Sell
8,756
-17,135
-66% -$462K ﹤0.01% 2600
2022
Q1
$724K Sell
25,891
-135,108
-84% -$3.82M ﹤0.01% 1814
2021
Q4
$4.64M Buy
160,999
+8,560
+6% +$249K 0.02% 674
2021
Q3
$4.36M Sell
152,439
-6,702
-4% -$198K 0.02% 672
2021
Q2
$4.71M Sell
159,141
-306
-0.2% -$9.03K 0.02% 648
2021
Q1
$4.67M Buy
159,447
+12,761
+9% +$377K 0.03% 590
2020
Q4
$4.3M Buy
146,686
+16,333
+13% +$492K 0.03% 585
2020
Q3
$4.02M Buy
130,353
+12,764
+11% +$393K 0.03% 532
2020
Q2
$3.55M Buy
+117,589
New +$3.49M 0.03% 543

Other funds holding DRSK

Cambridge Investment Research Advisors's DRSK Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Aptus Defined Risk ETF (DRSK) in Q4 2023, closing a stake of 15,893 shares — an estimated $370K sold.

Cambridge Investment Research Advisors first reported a position in DRSK in Q2 2020 and held it in 14 quarters. The position peaked at $4.71M in Q2 2021. 51 funds tracked by Wall St. Rank hold DRSK as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Aptus Defined Risk ETF position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,893 Aptus Defined Risk ETF shares in Q4 2023, an estimated $370K.
  • Cambridge Investment Research Advisors first reported a position in Aptus Defined Risk ETF in Q2 2020 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Aptus Defined Risk ETF position peaked at $4.71M in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.